Author Archives : Mohan Garikiparithi

Mohan Garikiparithi got his degree in medicine from Osmania University (University of Health Sciences). He practiced clinical medicine for over a decade before he shifted his focus to the field of health communications. During his active practice he served as the head of the Dept. of Microbiology in a diagnostic centre in India. On a three-year communications program in Germany, Mohan developed a keen interest in German Medicine (Homoeopathy), and other alternative systems of medicine. He now advocates treating different medical conditions without the use of traditional drugs. An ardent squash player, Mohan believes in the importance of fitness and wellness.

Advertisement

ALS protein clumps in brain explained

Post-mortem brain tissue analysis of people who have succumbed due to ALS reveal clumps of protein called TDP-43. A recent study by researchers at Johns Hopkins, involving brain tissue from mice and humans, sheds new light on the role of TDP-43 in normal cells and the reason for their accumulation in pathological conditions. The details ...click here to read more

Focus on personalized health called detrimental to public health

The increasing national focus on personalized or ‘precision’ medicine is misguided, distracting from broader investments to reduce health inequities and address the social factors that affect population health, two leading public health scholars argue in the New England Journal of Medicine. The article written by prominent professors in the field of public health sheds light on ...click here to read more

Advertisement

Pancreatic Cancer detected with urine test: Study

A recent discovery by researchers funded by the Pancreatic Cancer Research Fund (PCRF) could lead to a cheap, non-invasive test to detect early stages of pancreatic cancer in people who are in the high-risk category of developing this type of cancer. The research team, from Queen Mary University of London’s Barts Cancer Institute, has discovered ...click here to read more

Rare brain infection linked to MS drug: FDA

The Food and Drug Administration (FDA) has issued a warning to people taking the immunomodulator drug, Gilenya, for the treatment of multiple sclerosis (MS). The warning follows two cases of progressive multifocal leukoencephalopathy (PML) being reported in patients taking Gilenya. PML is a rare and serious brain infection caused by a virus. The John Cunningham ...click here to read more

Liver’s stem cell source identified

Scientists have found the origin of new cells in the liver. After years of painstaking research, scientists at the Howard Hughes Medical Institute (HHMI) have identified stem cells in the liver that give rise to functional liver cells. Cells in the liver must constantly be replenished as cells die off, even in a healthy organ. ...click here to read more

Insomnia pill dosage could be cut in half: Study

New findings on insomnia pills question the standard prescribing dosages currently in practice. According to a new study done by researchers from the Perelman School of Medicine at the University of Pennsylvania, people who depend on prescription sleeping pills to treat chronic insomnia may get relief from as little as half the drugs they are ...click here to read more

Advertisement